Robert Nolen is a Clinical Research Manager at Qbtech, contributing his expertise since 2022. He brings over 20 years of experience in pharmaceutical and medical device research, with a strong background in clinical trial management and regulatory compliance. Robert earned a BS in Psychology from the University of Texas in 1997.

Throughout his career, Robert has played a pivotal role in numerous ADHD medication trials that have led to the approval of treatments, helping expand options for patients and contributing to publications in the field. At Qbtech, he oversees clinical trials for innovative tools that provide objective ADHD assessments, supporting evidence-based care. Robert is particularly proud of his work with Qbtech and values the shared passion of his team for advancing ADHD assessment and treatment.

Outside of work, Robert enjoys traveling to Croatia, spending time with family, and staying active—having run track and played football during college.